The Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2019

In this online program experts discuss how to leverage 10 key clinical biomarkers to enhance patient care across multiple cancers. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium in Chicago and then download the biomarker summary resources to learn more about how to use biomarkers to select optimal therapy for your patients with cancer.

Share

Program Content

Activities

Biomarker: MMRd/MSI
Integrating MMRd/MSI Testing for Solid Tumors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: PD-L1
Using PD-L1 to Guide Therapy in the Clinic
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: BRCA
The Role of BRCA and Defective DNA Damage Repair
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarkers: BRAF, MAPK, and HER2
Targets Affecting Cellular Communication and Survival: BRAF, MAPK, and HER2
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarkers: <i>NTRK, ROS1, FGFR, RET</i>
Realizing the Promise of Targeted Therapies in Cell Signaling: NTRK, ROS1, FGFR, RET
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2019

Expires: June 01, 2020

Activities

Targeting RET
Targeting RET: Where We Are Today
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2019

Expires: July 23, 2020

Activities

Biomarker: <i>BRAF</i>
Biomarker Summary: BRAF
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: <i>BRCA1/2</i>
Biomarker Summary: BRCA1/2
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarkers: Emerging
Biomarker Summary: Newly Approved Indications and Emerging Biomarkers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: FGFR
Biomarker Summary: FGFR
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: <i>HER2</i>
Biomarker Summary: HER2
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: MSI/MMR
Biomarker Summary: MSI/MMR
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: PD-L1
Biomarker Summary: PD-L1
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: <i>RET</i>
Biomarker Summary: RET
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: <i>ROS1</i>
Biomarker Summary: ROS1
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

Biomarker: <i>NTRK</i>
Biomarker Summary: NTRK
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2019

Expires: May 29, 2020

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Foundation Medicine

Genentech TEXT Only

Loxo Oncology

Merck Oncology

Puma Biotechnology, Inc.